Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancer

dc.contributor.author	Antón Aparicio, Luis Miguel
dc.date.accessioned	2017-06-07T07:36:24Z
dc.date.available	2017-06-07T07:36:24Z
dc.date.issued	2014
dc.identifier.issn	1078-0432
dc.identifier.uri	http://hdl.handle.net/20.500.11940/8460
dc.language.iso	eng
dc.title	Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancer
dc.type	Artigo	es
dc.authorsophos	de Bono, J. S.
dc.authorsophos	Piulats, J. M.
dc.authorsophos	Pandha, H. S.
dc.authorsophos	Petrylak, D. P.
dc.authorsophos	Saad, F.
dc.authorsophos	Aparicio, L. M.
dc.authorsophos	Sandhu, S. K.
dc.authorsophos	Fong, P.
dc.authorsophos	Gillessen, S.
dc.authorsophos	Hudes, G. R.
dc.authorsophos	Wang, T.
dc.authorsophos	Scranton, J.
dc.authorsophos	Pollak, M. N.
dc.identifier.doi	10.1158/1078-0432.ccr-13-1869
dc.identifier.pmid	24536060
dc.identifier.sophos	15297
dc.journal.title	CLINICAL CANCER RESEARCH
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña::Oncoloxía médica
dc.page.initial	1925
dc.page.final	34
dc.rights.accessRights	openAccess
dc.typesophos	Artículo Original
dc.volume.number	20

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.